Biotech sector crafts response to R&D tax incentive review

11 October 2016 - AusBiotech members are invited to gather at briefings in Sydney, Brisbane and Melbourne to contribute to ...

Read more →

Why the drug industry and its critics are both wrong about how R&D spending affects pricing

6 October 2016 - The drug industry often claims that high prices are due to its high R&D costs, while ...

Read more →

Bill Ferris defends R&D reform proposals

5 October 2016 - Fewer than 1% of the 10,000 companies receiving cash refunds as part of the research and development ...

Read more →

New biomedical fund to capitalise on our research and entrepreneurial strengths

3 August 2016 - A new fund to accelerate the development and commercialisation of Australian biomedical discoveries is now officially launched. ...

Read more →

New fund set up to support research into medicines usage in NZ

8 June 2016 - Why do people not take all the medicine prescribed for them? Why are there differences in the ...

Read more →

Fund to bridge biomedical research to market gaps

10 December 2015 - The Australian Government’s $250 million Biomedical Translation Fund will bridge the gap between research and commercialisation of ...

Read more →